[{"NetIncomeLoss_1_Q1_USD":-16793000.0,"RestrictedCashCurrent_0_Q1_USD":147000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":53600000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-204000.0,"Depreciation_1_Q1_USD":236000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":1022547.0,"AssetsCurrent_0_Q1_USD":275295000.0,"GainLossOnSaleOfPropertyPlantEquipment_1_Q1_USD":-29000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":5375811.0,"UnrecognizedTaxBenefits_0_Q1_USD":0.0,"CommonStockSharesIssued_0_Q1_shares":36697808.0,"Assets_0_Q1_USD":278908000.0,"ShareBasedCompensation_1_Q1_USD":2698000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":844000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":371000.0,"InterestReceivableCurrent_0_Q1_USD":6000.0,"LiabilitiesNoncurrent_0_Q1_USD":333000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":36643205.0,"ResearchAndDevelopmentExpense_1_Q1_USD":9913000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":889000.0,"ProceedsFromStockPlans_1_Q1_USD":175000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":16000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":0.0,"CommonStockValue_0_Q1_USD":4000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-5499000.0,"AccruedEmployeeBenefitsCurrent_0_Q1_USD":1079000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":267514000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":20000.0,"Liabilities_0_Q1_USD":6443000.0,"OperatingLeaseLiability_0_Q1_USD":868000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":6914000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":546000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":808000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":21000.0,"CommonStockSharesAuthorized_0_Q1_shares":300000000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-20136000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":81000.0,"LiabilitiesCurrent_0_Q1_USD":6110000.0,"AccountsPayableCurrent_0_Q1_USD":1496000.0,"NonoperatingIncomeExpense_1_Q1_USD":34000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":7511000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":2698000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":371000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0701,"AdditionalPaidInCapital_0_Q1_USD":399532000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":267719000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":175000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":97000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":2711000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":87000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":1078000.0,"RestrictedCashNoncurrent_0_Q1_USD":58000.0,"DeferredFinanceCostsCurrentNet_0_Q1_USD":117000.0,"OperatingIncomeLoss_1_Q1_USD":-16827000.0,"InvestmentIncomeInterest_1_Q1_USD":18000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":278908000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":2698000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":848000.0,"OperatingExpenses_1_Q1_USD":16827000.0,"CommonStockSharesOutstanding_0_Q1_shares":36697808.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.46,"OtherLiabilitiesCurrent_0_Q1_USD":1166000.0,"StockholdersEquity_0_Q1_USD":272465000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":204000.0,"RestrictedCashAndCashEquivalents_0_Q1_USD":58000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-127071000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-19794000.0,"ProfitLoss_1_Q1_USD":-16793000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":694000.0,"Ticker":"STOK","CIK":"1623526","name":"STOKE THERAPEUTICS, INC.","OfficialName":"Stoke Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"702726891.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210510"}]